SITC 2025
November 7, 2025 - November 8, 2025
Houson, TX
With the fall conference calendar in full swing, Nordic Bioscience is gearing up for the Society for Immunotherapy of Cancer (SITC) Annual Meeting 2025, taking place November 5–9 in Houston, Texas. Our team will be present November 7-8.
SITC 2025 brings together leaders in immuno-oncology to explore cutting-edge science in cancer immunotherapy. At this year’s event, Nordic Bioscience will join the discussion around biomarker strategies for the tumor microenvironment, with a particular focus on tumor fibrosis.
A central part of our contribution is the nordicPRO-C3™ biomarker, which captures active remodeling of type III collagen—a key feature of cancer-associated fibroblast (CAF) activity. Recognized with a Letter of Support from the FDA, nordicPRO-C3™ is gaining traction as a non-invasive biomarker to monitor tumor fibrosis, immune exclusion, and treatment response across a range of solid tumors.
We look forward to connecting with the immuno-oncology community at SITC to help advance precision approaches in cancer therapy.